Business Wire

MO-ASM-GLOBAL

23.5.2024 18:01:32 CEST | Business Wire | Press release

Share
WORLD’S MOST ICONIC ROCK BAND, THE ROLLING STONES, SELECTS THUNDER RIDGE NATURE ARENA AS DESTINATION FOR FINAL NORTH AMERICAN PERFORMANCE

Bass Pro Shops Big Cedar Lodge announced today that on July 21 the Ozarks will rock as the ancient hills, valleys and lakes never have when the world’s greatest rock-and-roll band, The Rolling Stones, light up Thunder Ridge Nature Arena for the last performance on their final North American tour.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523211894/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Rendering of Thunder Ridge Nature Arena (Graphic: Business Wire)

The concert promises to be one of the most memorable and highly anticipated concert events ever. It is a pairing of the World’s Greatest Rock-and-Roll Band and the most breathtaking and awe-inspiring outdoor amphitheater in all of North America.

The Thunder Ridge concert stop is part of the “Hackney Diamonds Tour ’24” for The Rolling Stones, which includes 20 performances in 16 cities. Tickets will go on sale Friday, May 31, and will be available at ThunderRidgeNatureArena.com.

“We’re honored to host The Rolling Stones at Thunder Ridge Nature Arena and to showcase the amazing beauty of the Ozarks to music fans of all generations,” said Johnny Morris, visionary conservationist and founder of Bass Pro Shops. “The Stones are the most iconic rock-and-roll band ever, and we know they will put on a remarkable show that no one will ever forget! Their appearance will become a part of the history of this beautiful mountain in the Ozarks.”

Thunder Ridge is a world-class destination admired by legends of rock.

Representatives from The Rolling Stones scouted Thunder Ridge by attending the sold-out Garth Brooks concert in September 2022. After attending the show, the advance team reported back that Thunder Ridge was one of the most extraordinary and beautiful event venues they had ever seen.

A legendary night of entertainment began on a fishing trip with two of the leading conservationists of our time.

A partnership between The Rolling Stones, the Ozarks and Johnny Morris is something few would have expected; but, in fact, this is a relationship decades in the making. More than 20 years ago, the Stones renowned keyboard and piano player, Chuck Leavell, joined Johnny Morris to celebrate the opening of a Bass Pro Shops near Chuck’s home in Macon, Georgia. Out of this shared experience, Johnny and Chuck developed a special friendship founded on conservation, a love of the outdoors and a few remarkable shared fishing adventures. And now their adventure continues with a concert unlike anything that has ever been seen in the Ozarks.

A noted conservationist, Chuck Leavell is one of only three recipients of an Honorary Forest Ranger award from the U.S. Forest Service and is also a past recipient of the National Outstanding Tree Farmer award. Johnny Morris, is also a legend in conservation and is a recipient of the prestigious Audubon Medal, considered by many to be the highest award in conservation. In the 114-year history of Audubon there have been only 57 recipients for this prestigious award.

Awe-inspiring, nature-based entertainment venue.

The Rolling Stones concert at Thunder Ridge Nature Arena underscores Johnny’s commitment to create one of the finest outdoor entertainment venues in North America and shares the beauty of his beloved Ozarks with others for generations to come. It’s more than just a place for spectacular concerts, rodeos and conventions. The property has been placed in a not-for-profit foundation, and all proceeds from events at the arena will go to further enhance the facilities and support conservation.

Located on about 1,200 acres near Ridgedale, Thunder Ridge is adjacent to the Bass Pro Shops Big Cedar Lodge on land originally purchased by Johnny Morris about 30 years ago. For the past decade, it has accommodated large gatherings, including concerts by Garth Brooks, Hank Williams Jr., Chris Janson, Dierks Bentley, Tracy Lawrence and other major acts.

It also has hosted air shows, hot air balloon shows, the U.S. Open Bowfishing Championship, the U.S. Open National Bass Tournament, the National 4-H Youth Council, rodeos, conventions, symposiums and special events and is set to host nature-based activities for all ages and interests for years to come.

Thunder Ridge is the latest jewel in Big Cedar Lodge’s proud tradition of hosting world-class hospitality and entertainment experiences that span a variety of recreational markets.

The vision for the future is to continue to host a wide variety of world-class outdoor events. The Rolling Stones performance is only the latest in a summer full of marquee concerts already announced for Thunder Ridge. This lineup includes:

  • May 25 – Morgan Wallen
  • June 13 – Chris Stapleton
  • June 15 – Fuerza Regida
  • July 21 – The Rolling Stones
  • July 27 – Luke Bryan
  • Aug. 31 – Slightly Stoopid & Dirty Heads w / HIRIE
  • Sept. 8 – Imagine Dragons
  • Sept. 21 – Pitbull

More than six decades of rock-and-roll royalty.

Over the last 60 years, The Rolling Stones have defined the rock-and-roll movement, led by vocalist Mick Jagger and guitarist Keith Richards. The group has estimated album sales of 250 million, making them one of the best-selling musical artists of all time.

The Stones have released 30 studio albums, 23 live albums and 12 official compilation albums; and CNN has called them “far and away the most successful act in rock today.” The Grammy Award-winning band was inducted into the Rock & Roll Hall of Fame in 1989 and the U.K. Music Hall of Fame in 2004 and have been ranked by music-industry watchdogs Billboard magazine and Rolling Stone magazine as one of the greatest bands of all time.

This tour is in support of their widely heralded Hackney Diamonds album release from 2022, which received rave reviews from fans and music critics everywhere.

About Thunder Ridge Nature Arena

Thunder Ridge Nature Arena is a breathtaking outdoor amphitheater nestled in the heart of the Ozarks in Ridgedale, Missouri, just a few miles south of Branson. Situated on over 1,200 acres of land dedicated to conservation, the venue offers stunning views of Table Rock Lake and the Boston Mountains of Arkansas. Thunder Ridge Nature Arena is part of the Johnny Morris Conservation Foundation, dedicated to preserving and celebrating the natural beauty of the Ozarks. All venue proceeds go directly to conservation efforts to protect the land, wildlife and natural habitats of the Ozark region.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523211894/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye